Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancer

A. Chytła, S. Rattay, B. Akgül, M. Sztacho

. 2025 ; 24 (1) : 39. [pub] 20250206

Language English Country England, Great Britain

Document type Journal Article, Review

Grant support
Fond F Program Charles University
Cooperatio Program: research area "Oncology and Haematology" Charles University
AK 42/10-1 German Research Foundation
NPO EXCELES, ID Project No. LX22NPO5102 National Institute for Cancer Research

The development of metastasis is a leading cause of cancer-related death that involves specific changes in the plasma membrane (PM) and nucleus of cancer cells. Elevated levels of membrane lipids, including sphingomyelin, cholesterol, and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), in the PM, contribute to changes in membrane rigidity, lipid raft formation, and actin polymerisation dynamics, processes that drive cell invasion. This review discusses the relationship between well-studied cytoplasmic phosphoinositides and their lesser-known nuclear counterparts, highlighting their functional role in metastatic progression. Nuclear phosphoinositides, particularly PI(4,5)P2, are essential for regulating transcription factors and chromatin organisation, thereby shaping gene expression patterns. We also explore the role of PI(4,5)P2 and its metabolism in cancer cell invasiveness and metastasis, proposing a model in which the dysregulation of cytosolic and/or nuclear PI(4,5)P2 pool triggers malignant transformation. Understanding the PI(4,5)P2-related mechanisms underlying metastasis may provide insights into potential therapeutic targets, paving the way for more effective therapies and improved patient outcomes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009926
003      
CZ-PrNML
005      
20250429134959.0
007      
ta
008      
250415s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12944-025-02452-6 $2 doi
035    __
$a (PubMed)39915829
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Chytła, Agnieszka $u Laboratory of Cancer Cell Architecture, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, 128 00, Czech Republic
245    10
$a Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancer / $c A. Chytła, S. Rattay, B. Akgül, M. Sztacho
520    9_
$a The development of metastasis is a leading cause of cancer-related death that involves specific changes in the plasma membrane (PM) and nucleus of cancer cells. Elevated levels of membrane lipids, including sphingomyelin, cholesterol, and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), in the PM, contribute to changes in membrane rigidity, lipid raft formation, and actin polymerisation dynamics, processes that drive cell invasion. This review discusses the relationship between well-studied cytoplasmic phosphoinositides and their lesser-known nuclear counterparts, highlighting their functional role in metastatic progression. Nuclear phosphoinositides, particularly PI(4,5)P2, are essential for regulating transcription factors and chromatin organisation, thereby shaping gene expression patterns. We also explore the role of PI(4,5)P2 and its metabolism in cancer cell invasiveness and metastasis, proposing a model in which the dysregulation of cytosolic and/or nuclear PI(4,5)P2 pool triggers malignant transformation. Understanding the PI(4,5)P2-related mechanisms underlying metastasis may provide insights into potential therapeutic targets, paving the way for more effective therapies and improved patient outcomes.
650    _2
$a lidé $7 D006801
650    12
$a fosfatidylinositol-4,5-difosfát $x metabolismus $7 D019269
650    12
$a buněčná membrána $x metabolismus $7 D002462
650    12
$a nádory $x metabolismus $x patologie $x genetika $7 D009369
650    12
$a signální transdukce $7 D015398
650    12
$a buněčné jádro $x metabolismus $7 D002467
650    _2
$a zvířata $7 D000818
650    _2
$a membránové mikrodomény $x metabolismus $7 D021962
650    _2
$a metastázy nádorů $7 D009362
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Rattay, Stephanie $u Institute of Virology, Medical Faculty, University of Cologne, University Hospital Cologne, 50935, Cologne, Germany
700    1_
$a Akgül, Baki $u Institute of Virology, Medical Faculty, University of Cologne, University Hospital Cologne, 50935, Cologne, Germany $u National Reference Center for Papilloma- and Polyomaviruses, Institute of Virology, Faculty of Medicine, University Hospital Cologne, University of Cologne, 50935, Cologne, Germany
700    1_
$a Sztacho, Martin $u Laboratory of Cancer Cell Architecture, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, 128 00, Czech Republic. martin.sztacho@lf1.cuni.cz
773    0_
$w MED00008241 $t Lipids in health and disease $x 1476-511X $g Roč. 24, č. 1 (2025), s. 39
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39915829 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134954 $b ABA008
999    __
$a ok $b bmc $g 2311354 $s 1247007
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 24 $c 1 $d 39 $e 20250206 $i 1476-511X $m Lipids in health and disease $n Lipids Health Dis $x MED00008241
GRA    __
$a Fond F Program $p Charles University
GRA    __
$a Cooperatio Program: research area "Oncology and Haematology" $p Charles University
GRA    __
$a AK 42/10-1 $p German Research Foundation
GRA    __
$a NPO EXCELES, ID Project No. LX22NPO5102 $p National Institute for Cancer Research
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...